Two studies in the April issue of Psychiatric Services discuss barriers for the elderly taking psychiatric medicines in Canada and the United States. One article, an NIMH-funded study of co-pays in British Columbia between 1997 and 2005, found that copays delayed seniors from obtaining antidepressant medicines. Another study discussed the United States, and the implications of excluding the anti-anxiety benzodiazepines from Medicare Part D.
Two studies in the April issue of Psychiatric Services discuss barriers for the elderly taking psychiatric medicines in Canada and the United States. One article, an NIMH-funded study of co-pays in British Columbia between 1997 and 2005, found that copays delayed seniors from obtaining antidepressant medicines. Another study discussed the United States, and the implications of excluding the anti-anxiety benzodiazepines from Medicare Part D.
